EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Systemic Sclerosis Dermal Fibroblast Exosomes Trigger Type 1 Interferon Responses in Keratinocytes via a TBK / JAK / STAT Signaling Axis

Jessica Bryon, Christopher W Wasson iD, Katja Koeppen, Francesca Chandler, Leon F Willis iD, Stefano Di Donato, Elliott Klein, Elton Zeqiraj, Rebecca L Ross iD, Francesco Del Galdo iD

Arthritis & Rheumatology · 2025-03 · 77 (3) · 322-334

DOI: 10.1002/art.43029 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arthritis & Rheumatology, online erschienen am 12.11.2024. Verfasst von Jessica Bryon und 9 weiteren Autor:innen. Beteiligte Einrichtung: University of Leeds, Leeds, United Kingdom. Hauptthemen laut MEDLINE: Scleroderma, Systemic, Keratinocytes, Exosomes, Interferon Type I. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Boehringer Ingelheim, Wellcome Trust PhD studentship, national institute for health and care research (NIHR) Leeds biomedical research centre (BRC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Activation of type I interferon (IFN) response has been shown to correlate with disease activity in systemic sclerosis (SSc). It is currently unknown whether the tissue‐specific type I IFN activation is a consequence of the response observed in blood or rather its source. Exosomes from SSc fibroblasts were recently shown to activate macrophages in vitro. Here, we aimed to determine the source of type I IFN signature in SSc skin biopsies and the potential role of exosomes from SSc dermal fibroblasts in the process.

Methods

Skin biopsies were obtained from the forearms of healthy patients and of those with SSc and processed for dermal fibroblasts and keratinocytes. Exosomes were isolated from healthy and SSc dermal fibroblast supernatants by ultracentrifugation and added to human skin keratinocytes. Keratinocyte transcriptome was analyzed by RNA sequencing (RNA‐seq) analysis. TANK‐binding kinase (TBK) and JAK were inhibited using a small molecule inhibitor (GSK8612) and tofacitinib, respectively.

Results

SSc skin biopsies showed the highest levels of type I IFN response in the epidermal layer. RNA‐seq analysis of keratinocytes transcriptome following exposure to dermal fibroblast exosomes showed strong up‐regulation of IFN signature genes induced by SSc exosomes compared to healthy control. Inhibition of TBK or JAK activity suppressed the up‐regulation of the IFN signature induced by SSc exosomes.

Conclusion

IFN activation of SSc keratinocytes is dependent on their crosstalk with dermal fibroblasts and inducible by extracellular exosomes. Our data indicate that SSc fibroblast exosomes contribute to the type I IFN activation in SSc skin through activation of pattern recognition receptors upstream of TBK.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Scleroderma, SystemicKeratinocytesExosomesInterferon Type IFibroblastsProtein Serine-Threonine KinasesHumansSignal TransductionSkinJanus KinasesFemalePyrimidinesPiperidinesMiddle AgedMaleSTAT Transcription Factors

Substanzen

Interferon Type IProtein Serine-Threonine KinasesTBK1 protein, humantofacitinibJanus KinasesPyrimidinesPiperidinesSTAT Transcription Factors

Autor:innen und Institutionen

  • University of Leeds, Leeds, United Kingdom.
  • Boehringer Ingelheim, Ridgefield, Connecticut.
  • University of Leeds and the National Institute for Health and Care Research Leeds Musculoskeletal Biomedical Research Centre, Leeds, United Kingdom.

ORCID-Profile: Christopher W Wasson, Leon F Willis, Rebecca L Ross, Francesco Del Galdo

Förderung

  • Boehringer Ingelheim
  • Wellcome Trust PhD studentship
  • national institute for health and care research (NIHR) Leeds biomedical research centre (BRC)
  • Wellcome Trust
  • NIHR BRC PhD studentship
  • Wellcome Senior Research Fellowship
  • National Institute for Health and Care Research

Zitieren

APA

Bryon, J., Wasson, C. W., Koeppen, K., Chandler, F., Willis, L. F., Di Donato, S., Klein, E., Zeqiraj, E., Ross, R. L., & Del Galdo, F. (2025). Systemic Sclerosis Dermal Fibroblast Exosomes Trigger Type 1 Interferon Responses in Keratinocytes via a TBK / JAK / STAT Signaling Axis. Arthritis & Rheumatology, 77(3), 322-334. https://doi.org/10.1002/art.43029

Vancouver

Bryon J, Wasson CW, Koeppen K, Chandler F, Willis LF, Di Donato S, et al. Systemic Sclerosis Dermal Fibroblast Exosomes Trigger Type 1 Interferon Responses in Keratinocytes via a TBK / JAK / STAT Signaling Axis. Arthritis & Rheumatology. 2025;77(3):322-334. doi:10.1002/art.43029

BibTeX
@article{Bryon2025,
  author = {Bryon, Jessica and Wasson, Christopher W and Koeppen, Katja and Chandler, Francesca and Willis, Leon F and Di Donato, Stefano and Klein, Elliott and Zeqiraj, Elton and Ross, Rebecca L and Del Galdo, Francesco},
  title = {Systemic Sclerosis Dermal Fibroblast Exosomes Trigger Type 1 Interferon Responses in Keratinocytes via a TBK / JAK / STAT Signaling Axis},
  journal = {Arthritis & Rheumatology},
  year = {2025},
  volume = {77},
  number = {3},
  pages = {322--334},
  doi = {10.1002/art.43029}
}
Kostenlos starten →